Stuart Essig News Today

Point72 Europe London LLP raised its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 54.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 719,663 shares of the life sciences company’s stock after buying an additional 255,201 shares during the quarter. […]

Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten analysts that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. […]

Integra LifeSciences (NASDAQ:IART – Free Report) had its target price lifted by Citigroup from $24.00 to $28.00 in a research report report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the life sciences company’s stock. IART has been the topic of several other reports. StockNews.com cut Integra LifeSciences from a […]

Integra LifeSciences (NASDAQ:IART – Free Report) had its price objective lifted by Citigroup from $24.00 to $28.00 in a report released on Wednesday morning, Benzinga reports. They currently have a neutral rating on the life sciences company’s stock. A number of other brokerages have also recently commented on IART. StockNews.com cut Integra LifeSciences from a […]

Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript February 28, 2024 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9. Integra LifeSciences Holdings Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]

Integra LifeSciences (Nasdaq: IART) announced today that President and CEO Jan De Witte informed the board of his intention to retire.

By Will Feuer Integra LifeSciences Holdings Chief Executive Jan De Witte said he plans to retire this year after less than three years at the helm of the...

Integra LifeSciences Holdings Corporation (IART) reported fourth quarter GAAP net income of $19.8 million, or $0.25 per share, compared to $52.9 million, or $0.63 per share, in the prior year.